The Regents of the University of Colorado; a body corporate
发明人:
申请号：
EP16787266.2
公开号：
EP3288921A4
申请日:
2016.04.29
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to indoline and indolenine alkaloid compounds. In particular, indoline and indolenine alkaloid compounds of the invention have antibacterial activity and/or are capable of re-sensitizing the susceptibility of methicillin-resistant S. aureus to a β-lactam antibiotic. The present invention also relates to a method for producing and using the same.
